Get the Stockscreener App
55.98
1.53%
-0.87
After Hours:
56.25
0.27
+0.48%
Boston Scientific Corp stock is traded at $55.98, with a volume of 12.54M.
It is down -1.53% in the last 24 hours and down -10.89% over the past month.
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.
See More
Previous Close:
$56.85
Open:
$57.005
24h Volume:
12.54M
Relative Volume:
0.71
Market Cap:
$83.21B
Revenue:
$20.62B
Net Income/Loss:
$3.56B
P/E Ratio:
23.47
EPS:
2.3847
Net Cash Flow:
$3.48B
1W Performance:
-4.23%
1M Performance:
-10.89%
6M Performance:
-43.40%
1Y Performance:
-46.30%
1-Day Range:
$55.88
$57.01
1-Week Range:
$55.88
$58.17
52-Week Range:
$55.88
$109.50
Boston Scientific Corp Stock (BSX) Company Profile
Name
Boston Scientific Corp
Sector
Industry
Phone
508-683-4000
Address
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
Compare BSX vs ABT, SYK, MDT, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BSX
Boston Scientific Corp
|
55.98 | 84.50B | 20.62B | 3.56B | 3.48B | 2.3847 |
ABT
Abbott Laboratories
|
87.17 | 152.48B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
295.25 | 111.40B | 25.27B | 3.34B | 4.57B | 8.6358 |
MDT
Medtronic Plc
|
77.79 | 100.53B | 35.48B | 4.64B | 5.41B | 3.582 |
EW
Edwards Lifesciences Corp
|
82.91 | 48.04B | 6.30B | 1.07B | 1.34B | 1.8406 |
Boston Scientific Corp Stock (BSX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-30-26 | Downgrade | Raymond James | Strong Buy → Outperform |
| Oct-03-25 | Downgrade | Erste Group | Buy → Hold |
| Sep-08-25 | Upgrade | Oppenheimer | Perform → Outperform |
| Jun-16-25 | Initiated | Leerink Partners | Outperform |
| Apr-16-25 | Upgrade | Needham | Hold → Buy |
| Jan-10-25 | Upgrade | Deutsche Bank | Hold → Buy |
| Oct-18-24 | Downgrade | Needham | Buy → Hold |
| May-30-24 | Initiated | Goldman | Buy |
| Feb-01-24 | Upgrade | Mizuho | Neutral → Buy |
| Jul-19-23 | Initiated | Robert W. Baird | Outperform |
| Jun-30-23 | Initiated | CL King | Buy |
| May-30-23 | Resumed | Morgan Stanley | Overweight |
| Mar-29-23 | Initiated | UBS | Buy |
| Dec-22-22 | Initiated | Mizuho | Neutral |
| Dec-20-22 | Resumed | Citigroup | Buy |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Jul-06-22 | Initiated | Wolfe Research | Outperform |
| May-27-22 | Upgrade | Needham | Hold → Buy |
| Apr-13-22 | Resumed | Truist | Buy |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Dec-10-21 | Initiated | RBC Capital Mkts | Outperform |
| May-26-21 | Downgrade | Needham | Buy → Hold |
| May-25-21 | Initiated | Barclays | Overweight |
| Apr-15-21 | Initiated | Atlantic Equities | Overweight |
| Sep-17-20 | Initiated | Truist | Buy |
| Sep-11-20 | Initiated | Wolfe Research | Peer Perform |
| Apr-22-20 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-01-20 | Upgrade | Goldman | Neutral → Buy |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-13-20 | Initiated | Goldman | Neutral |
| Feb-06-20 | Resumed | BTIG Research | Buy |
| Dec-30-19 | Reiterated | Cowen | Outperform |
| Dec-19-19 | Downgrade | Needham | Strong Buy → Buy |
| Sep-05-19 | Resumed | JP Morgan | Overweight |
| Sep-03-19 | Resumed | Barclays | Overweight |
| May-13-19 | Upgrade | Evercore ISI | In-line → Outperform |
| Nov-28-18 | Initiated | UBS | Buy |
| Oct-16-18 | Initiated | Barclays | Overweight |
| Oct-02-18 | Reiterated | Morgan Stanley | Overweight |
| Sep-07-18 | Reiterated | Needham | Strong Buy |
| Sep-04-18 | Upgrade | Jefferies | Hold → Buy |
| Jul-06-18 | Reiterated | Needham | Strong Buy |
| Jun-27-18 | Initiated | Bernstein | Outperform |
| Apr-26-18 | Reiterated | Needham | Strong Buy |
View All
Boston Scientific Corp Stock (BSX) Latest News
Boston Scientific shareholders approve charter amendments and board elections - Investing.com
Boston Scientific (NYSE: BSX) investors approve charter changes and board slate - Stock Titan
Boston Scientific stock hits 52-week low at 56.04 USD - Investing.com
Boston Scientific (BSX) EVP manages tax on 1,802 RSU vesting - Stock Titan
Boston Scientific (NYSE: BSX) EVP exercises RSUs and withholds shares for taxes - Stock Titan
BSX Stock Quote Price and Forecast - CNN
Penumbra earnings in focus as Boston Scientific deal looms - Investing.com
BSX DEADLINE TODAY: ROSEN, LEADING INVESTOR COUNSEL, Encourages Boston Scientific Corporation Investors to Secure Counsel Before Important May 4 Deadline in Securities Class ActionBSX - TMX Newsfile
Piper Sandler reiterates Boston Scientific stock rating on survey - Investing.com
Boston Scientific maps out May conference appearance, July 29 Q2 call - Stock Titan
Boston Scientific announces participation in Bernstein's 42nd Annual Strategic Decisions Conference and conference call discussing second quarter 2026 results - Yahoo Finance
BSX DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Boston Scientific Corporation Investors to Secure Counsel Before Important May 4 Deadline in Securities Class ActionBSX - Scott Coop
Bronstein, Gewirtz & Grossman LLC Urges Boston Scientific Corporation Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire Inc.
BSX Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026 - marketscreener.com
Boston Scientific Corporation (NYSE:BSX) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Boston Scientific Corp. Opens with 4.84% Gain, Outperforming S&P 500's 1.05% Increase - Markets Mojo
Boston Scientific Corporation (BSX): Billionaire Tom Steyer Is Loading Up on This Stock - Insider Monkey
BSX 72 HOUR DEADLINE REMINDER: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026 - marketscreener.com
Boston Scientific AGM: $20B 2025 Sales, Governance Votes Pass, Special Meeting Proposals Fail - Yahoo Finance
Boston Scientific Q1 2026 Financial Results: Earnings, Risk Factors, and Comprehensive Performance Overview - Minichart
Teza Capital Management LLC's Boston Scientific Corp(BSX) Holding History - GuruFocus
Boston Scientific Corp. stock underperforms Friday when compared to competitors - MarketWatch
BSX SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026 - ChartMill
Wall Street Analysts Think Boston Scientific (BSX) Is a Good Investment: Is It? - Yahoo Finance
Inside Boston Scientific's $15 billion offer for Alameda's largest employer - The Business Journals
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff - GlobeNewswire
Oppenheimer Asset Management Inc. Sells 21,543 Shares of Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific (NYSE: BSX) grows Q1 2026 sales 11.6% with active M&A - Stock Titan
Danske Bank A S Has $82.48 Million Stock Holdings in Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Corporation $BSX Shares Sold by GC Wealth Management RIA LLC - MarketBeat
Is Boston Scientific Corporation (BSX) One of the Best Medical Device Stocks to Invest in Right Now? - Insider Monkey
Boston Scientific Corp. Stock Plummets to New 52-Week Low of $56.18 - Markets Mojo
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Boston Scientific Corporation of Class Action Lawsuit and Upcoming DeadlinesBSX - ChartMill
Deadline Soon: Boston Scientific Corporation (BSX) Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit - ChartMill
Boston Scientific Corporation $BSX Shares Acquired by Jennison Associates LLC - MarketBeat
Boston Scientific Corporation (BSX) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Boston Scientific Corp. Stock (US10117L1017): Q1 2026 Earnings Beat Expectations with Strong Growth - AD HOC NEWS
Boston Scientific Stock: Is Wall Street Bullish or Bearish? - Yahoo Finance
Jim Cramer on Boston Scientific: “I Think They Can Come Back” - Insider Monkey
BSX DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Boston Scientific Corporation Investors to Secure Counsel Before Important May 4 Deadline in Securities Class Action - GlobeNewswire Inc.
BSX UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026 - marketscreener.com
Boston Scientific Corporation (BSX): Stephen Mandel Opens New Position in Medical Device Firm - Insider Monkey
Vanguard (NYSE: BSX) discloses 111.1M-share holding in Boston Scientific - Stock Titan
Boston Scientific Corp. stock outperforms competitors despite losses on the day - MarketWatch
Boston Scientific Corporation $BSX Shares Sold by Wealthfront Advisers LLC - MarketBeat
SHAREHOLDER ALERT Securities Class Action Filed Against Boston Scientific Corporation (BSX) - TMX Newsfile
Polen Focus Growth Sold Its Stake in Boston Scientific (BSX) Over Competition Concerns - Yahoo Finance
Procedure using Boston Scientific device tops medication for heart rhythm problem - Reuters
2026-04-29 | BSX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Investors of Boston Scientific Corporation to Contact the Firm Today! | NYSE:BSX | Press Release - Stockhouse
M&T Bank Corp Trims Stake in Boston Scientific Corporation $BSX - MarketBeat
BSX DEADLINE: ROSEN, A LEADING AND RANKED FIRM, Encourages Boston Scientific Corporation Investors to Secure Counsel Before Important May 4 Deadline in Securities Class ActionBSX - TMX Newsfile
Boston Scientific Corp Stock (BSX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.65%
1.50%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):